|
|
|
|
|
|
|
|
|
|
|
06.10.25 - 08:00
|
KI fegt durch Büro-Welt: Holcim Zug entlässt und entlässt (Inside Paradeplatz)
|
|
|
Jede Woche landen zwei bis 4 Office-Mitarbeiter vor der Tür. Salami-Abbau bei Zement-Multi, dessen Aktie schiesst durch Decke.
Die Accenture beschäftigt über 750'000 Leute weltweit. Soeben verkündete die Chefin der IT-Beraterin, dass von KI überforderte Mitarbeiter ausscheiden würden. In der Schweiz ist womöglich das Gleiche im Gang. Bei der bekannten Holcim in Zug landen laut einer Quelle jede […]...
|
|
|
|
|
|
|
02.10.25 - 15:03
|
Accenture Appoints Shaheen Sayed as Chief Commercial Officer for Reinvention Services (Business Wire)
|
|
|
Matt Prebble to Lead Accenture in UK, Ireland & AfricaNEW YORK--(BUSINESS WIRE)--Accenture (NYSE: ACN) today announced that Shaheen Sayed has been appointed as Chief Commercial Officer of Reinvention Services. In this new role, Shaheen will be responsible for streamlining how Accenture delivers AI-enabled solutions that meet the evolving needs of clients for the AI era. She will play a critical role in integrating capabilities to drive sustainable growth and long-term client value. Shaheen will continue to be a member of the Global Management Committee.
She will be succeeded in her role as lead for Accenture in the UK, Ireland & Africa (UKIA) by Matt Prebble, who currently serves as Data & AI lead for EMEA. Matt will also become a member of the Global Management Committee.
"Shaheen Sayed's appointment as Chief Commercial Officer marks a significant step in our mission to drive transformative change for our clients. With her extensive experience in digital transformations, Shaheen is uniquely positio...
|
|
|
02.10.25 - 02:03
|
Blue Matter stellt mit Eva Kersey einen neuen Partner ein und baut damit seine Kompetenzen in Europa weiter aus (Business Wire)
|
|
|
LONDON--(BUSINESS WIRE)--Blue Matter freut sich mitteilen zu können, Eva Kersey als Partner mit Sitz in London für das Unternehmen gewonnen zu haben. Eva ist dem Team von Blue Matter am 16. September offiziell beigetreten und bringt umfangreiche Erfahrungen in der strategischen Beratung von Kunden aus den Bereichen Pharmazie, Biotechnologie und Medizintechnik mit.
Eva ist seit 2007 für Kunden aus dem Bereich Life Sciences tätig. Sie startete ihre Beraterkarriere bei PHP (jetzt Teil von Accenture). Seitdem bekleidete sie Führungs- und Partnerpositionen bei IMS Consulting, IQVIA und ClearView Healthcare Partners. Über die Jahre konnte sie Beratungserfahrung entlang der gesamten Wertschöpfungskette sammeln, wobei ihr Schwerpunkt auf der Entwicklung funktionsübergreifender Strategien lag. Sie hat sich vor allem auf Therapie- und Franchise-Strategien, Portfoliooptimierung sowie Preis-, Zugangs- und Evidenzstrategien spezialisiert. Außerdem verfügt sie über umfassende Expertise in allen Aspekten der ...
|
|
|
01.10.25 - 22:45
|
Grafton Resources Announces Change of Auditor (The Newswire)
|
|
|
VANCOUVER, BC – TheNewswire - October 1, 2025 – Grafton Resources Inc. (the ”Company”) (CSE: GFT) is pleased to announce that it has changed its auditor from Adam Sung Kim Ltd (“Former Auditor”) to DeVisser Gray LLP (“Successor Auditor”) effective October 1, 2025.
At the request of the Company, the Former Auditor resigned as the auditor of the Company effective October 1, 2025 and the board of directors of the Company appointed the Successor Auditor as the Company's auditor effective October 1, 2025, until the next annual general meeting of the Company.
There were no reservations in the Former Auditor's audit reports for any financial period during which the Former Auditor was the Company's auditor. There are no “reportable events” including disagreements, consultations, or unresolved issues as defined in National Instrument 51-102 – Continuous Disclosure Obligations (“NI 51-102”) (Part 4.11) between the Company and the Former Auditor.
In accordance with NI 51-102...
|
|
|
|
|
01.10.25 - 15:06
|
Blue Matter Hires New Partner, Eva Kersey, Further Strengthening Capabilities in Europe (Business Wire)
|
|
|
LONDON--(BUSINESS WIRE)--Blue Matter is pleased to announce that Eva Kersey has joined the firm as a Partner based in London. Eva officially joined the Blue Matter team on September 16, bringing a broad base of strategic consulting experience across pharmaceutical, biotech, and medical technology clients.
Eva has been serving life science clients since 2007. She began her consulting career at PHP (now a part of Accenture). Since then, she has served in leadership and Partner-level positions at IMS Consulting, IQVIA, and ClearView Healthcare Partners. Over the years, her consulting experience has spanned the full value chain, focusing on cross-functional strategy development. She brings a particular specialization in therapy and franchise strategy, portfolio optimization, and pricing, access and evidence strategy. She also brings significant expertise in all aspects of commercial strategy development for clinical-stage, pre-launch assets.
“I'm extremely excited to join the Blue Matter team,” Eva said....
|
|
|
|
|
|
|
|
|
|
|
30.09.25 - 08:01
|
Accenture To Buy Aidemy (AFX)
|
|
|
DUBLIN (dpa-AFX) - Accenture PLC (ACN), an Irish IT company, said on Tuesday that it is set to acquire Aidemy Inc. (5577.T), following a tender offer to boost LearnVantage, Accenture's learning an......
|
|
|
30.09.25 - 06:45
|
Accenture to Acquire Aidemy After Completing Tender Offer (Business Wire)
|
|
|
TOKYO--(BUSINESS WIRE)--Accenture (NYSE: ACN) is set to acquire Aidemy Inc. (President: Akihiko Ishikawa, Tokyo Stock Exchange Growth Market, Securities Code: 5577), after completing a tender offer. Integrating Aidemy into Accenture will further strengthen LearnVantage, Accenture's learning and reskilling service, which is helping clients around the world to identify and fill skill gaps in their businesses, and train their people in areas like generative AI which are essential for promoting enterprise reinvention utilizing advanced technologies. Additionally, this acquisition will strengthen Accenture's ability to provide end-to-end support for clients to reinvent with AI—from talent development to ensuring the sustained use of AI systems—by leveraging Aidemy's expertise in developing, implementing, and operating AI systems optimized for a wide range of tasks and industries.
During the tender offer period from August 15, 2025 (Friday) through September 29, 2025 (Monday), the number of Aidemy's com...
|
|
|
|
|
29.09.25 - 14:54
|
Accenture Announces Investment In Rehuman (AFX)
|
|
|
DUBLIN (dpa-AFX) - Accenture (ACN) said it has invested in Rehuman, a UK-based insurtech startup. The investment will enable Rehuman to scale its operations and further embed AI into insurer and b......
|
|
Börsentreff auf Facebook |
Börsentreff auf X |
Börsentreff auf Instagram
